Recipharm publ AB is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). It is divided in two business areas: Manufacturing Services, supplying a range of pharmaceutical products in different dosage forms, such as solid dose, semi solids, beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, among others; and Development

Find the latest RECIPHARM AB B (12R.BE) stock quote, history, news and other vital information to help you with your stock trading and investing.

(RECI B). Analyser, rekommendationer & riktkurser för Recipharm aktien. Stocks in Play – Recipharm klättrar på rapport men tyngre för spelbolag. Recipharm AB (publ) är ett läkemedelsföretag baserat i Sverige som är verksamt som en Contract Development and Manufacturing Organization. Det är indelat i EQT Infrastructure V launches offer to acquire all outstanding shares in Holders of Convertible Bonds in Recipharm AB (publ) made public. Recipharm – Svängigt värre! Inför Q3-rapporten från Recipharm hann aktien med att såväl sätta ett nytt All Time High på dryga 167 kr som att The market share for hyaluronic acid treatments has also recently grown, which companies, where OT Chemistry was acquired by Recipharm in June 2015.

Recipharm stock

Pagination. First page « First; Recipharm AB (publ) has received 0 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Recipharm AB (publ) has received 100.00% “outperform” votes from our community.

Recipharm AB Recipharm AB publ specializes in contract development and manufacture of pharmaceuticals. The Company manufactures products in forms that include solid dose, granulates and powders,

02/19. Vid kl 18.00 den 6 februari 2020 offentliggjorde Recipharm att man kommer Consort ansöka om avnotering från London Stock Exchange och Acceptperioden förlängs fram till och med den 26 februari. Recipharm kommer att avnoteras från Nasdaq Stockholm samtidigt som konvertiblerna i bolaget Emittent, 556498-8425 Recipharm AB (publ).

Mini Futures – Mini Futures — Nr Namn Frankfurt Stock Exchange. 9155 Allianz. 9156 Bayer AG Namens 9078 Börse Frankfurt, Frankfurt: Läs

The shares are currently trading at SEK232.6. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share. In accordance with the conditions of the offer, which are described in the Company’s prospectus, the Board of Directors of Recipharm intends to decide on new issue of a maximum of 10,443,038 shares of series B. Depending on the selling price, which is expected to be set within the price range of SEK 72-86 per share through a book-building process, the new issue will provide Recipharm with a minimum of approximately SEK 752 million and a maximum of approximately SEK 898 million in proceeds Köp aktier i - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Aktiehistorik, Recipharm AB. Övrigt; År. Information. 2020/21.

Det innebär att EQT IX Stock Broker-Corp- Own clients -Stockpicker. #bioArctic Gladiator har ökat i Bioarctic Recipharm Callidiatas SAAB per 31/10 intressant 2 -1,1 %. Utv. APTA, OMXS30. 1m: 22,3%, 8,1%. 12m: -4,8%, 58,8% 1m 3m 6m YTD 1y 3y 5y 10y All Aktiekurs Aptahem - Spotlight Stock Market.
Kinnevik investment investor relations

STOCKHOLM, Feb. 3, 2021 /PRNewswire/ -- On 14 December 2020, EQT IX 1 ("EQT IX"), through Roar BidCo AB 2 ("Roar BidCo"), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the "Convertible Bonds") ("Holders of Convertible Bonds") in Recipharm AB (publ) ("Recipharm" or the "Company") to tender all their shares 3 and Convertible Bonds to Roar Recipharm AB (publ) currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RCPHF will outperform the market and that investors should add to their positions of Recipharm AB (publ). Recipharm AB (publ) (OTCMKTS:RCPHF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk. Your Recipharm stock images are ready.

Recipharm, som är ett innehav i Stockpicker Newsletters Referensportfölj, lyfte 3,3 procent. Recipharm AB - Class B (RCPHF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Hyr bentley stockholm

Recipharm AB (publ) (OTCMKTS:RCPHF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

Emittent, 556498-8425 Recipharm AB (publ). Instrument, Shares Class A and Class B. Innehavare, Thomas Eldered.